Science42: DORA
AI research writing assistant that drafts structured, cited papers, reviews, grant proposals and abstracts against biomedical databases such as PubMed and bioRxiv.
Find alternatives to Science42: DORA
The pricing page (2026-09-03) renders discounted figures as current with higher list prices struck through: Professional $17/month or $175/year, Power User $250/year annual-only, plus a free tier (2 daily document generations, 5 Deep Research uses monthly) and custom Enterprise. Earlier reads showed the list prices as Advanced $35/mo or $350/yr and Professional $500/yr. Recorded at the discounted figures as the live rendering; a promotion that ends will make this stale. The page also offers a 'Self-host Builder' option with Docker images and a GitHub repository using the customer's own LLM API keys.
What it does
- Text generation
- Summarization
- Knowledge retrieval
Sources
- Pricing
-
Tiers published on the product page itself; https://pharma.ai/science42/dora 301s here. Fetched independently on two separate reads, with the price discrepancy noted above.
- Sold within
-
pharma.ai/dora (already cited pricing-page elsewhere on this record); self-serve product with independent subscription.
Also from Insilico Medicine
-
Pharma.AI Platform
End-to-end generative-AI platform spanning target discovery, molecular design and clinical-trial risk assessment for pharmaceutical research.
-
PandaOmics Platform
AI platform for therapeutic target identification, biomarker discovery, indication prioritization and drug repurposing over a multi-omics knowledge base.
-
PandaOmics Box Hardware
On-premise AI appliance running PandaOmics target and biomarker discovery locally with no external data transmission, sold in Server and Desktop editions.
-
Chemistry42 Platform
Generative small-molecule design platform combining de novo generation with physics-based methods, retrosynthesis, ADMET profiling and custom model training.
-
Biology42: Generative Biologics Platform
AI platform for de novo design and multi-property optimization of peptides, nanobodies and antibodies against specified targets and epitopes.
-
inClinico Application
Multimodal AI platform that forecasts the probability of success of individual clinical trials and scores alternative trial designs before implementation.
-
MMAI Gym Platform
Foundation-model training and benchmarking platform that fine-tunes a customer's own LLM on Insilico's proprietary pharma reasoning datasets and validates results in its automation lab.
Open Insilico Medicine in the directory
Something wrong here? Send a correction — quote this product id: insilico-medicine-science42-dora.